During the past decade, Baptist Health System Cancer Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baptist Health System Cancer Program" are "Colorectal Cancer" (2 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Baptist Health System Cancer Program" in a lesser frequency.

Most popular intervention types in "Baptist Health System Cancer Program" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "oxaliplatin" (2 trials), "FOLFOX regimen" (1 trials), "cisplatin" (1 trials), "fluorouracil" (1 trials) and "irinotecan hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health System Cancer Program" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Health System Cancer Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baptist Health System Cancer Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health System Cancer Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".